Provided by Tiger Trade Technology Pte. Ltd.

INSILICO

43.620
-3.700-7.82%
Volume:23.42M
Turnover:1.03B
Market Cap:25.52B
PE:-9.74
High:46.180
Open:45.800
Low:42.940
Close:47.320
52wk High:80.900
52wk Low:29.980
Shares:585.00M
HK Float Shares:585.00M
Volume Ratio:1.60
T/O Rate:4.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.480
ROE:--
ROA:-1.36%
PB:5.94
PE(LYR):-9.74
PS:24.07

Loading ...

InSilico Medicine Nominates Drug for Preclinical Testing in Autoimmune Diseases

MT Newswires Live
·
Yesterday

Movement Alert|INSILICO Falls 5.37% in Regular Trading, AI Pharma Sector Correction Weighs on Stock

Market Focus
·
Yesterday

Insilico Medicine Nominates ISM9546 as 35th Preclinical Candidate Targeting Autoimmune Diseases

Bulletin Express
·
Yesterday

Insilico Medicine (03696) Nominates Peripheral-Restricted VAV1 Molecular Glue Degrader with Potential for Treating Multiple Autoimmune Diseases

Stock News
·
Yesterday

Movement Alert|INSILICO Falls 5.7% in Regular Trading, AI Drug Sector Pullback Triggers Profit-Taking

Market Focus
·
Oct 08

INSILICO Issues 2.44 Million New Shares in September; Total Share Capital Rises to 585.12 Million

Bulletin Express
·
Oct 07

Movement Alert|INSILICO Falls 8.68% in Regular Trading, AI Pharma Sector Undergoes Collective Pullback

Market Focus
·
Oct 07

JPMorgan Unfazed by Rising Rates Impact on China Healthcare, Remains Bullish on Biotech and CXO

Stock News
·
Oct 06

INSILICO: JPMorgan Chase & Co. Disposes of Shares, Long Position Falls to 6.93%

HK Disclosure
·
Oct 05

Movement Alert|INSILICO Falls 5.16% in Regular Trading, Life Sciences Sector Under Broad Selling Pressure

Market Focus
·
Oct 02

Hong Kong Stocks Rise on Lower Oil, Tech Optimism; InSilico Jumps 8%

MT Newswires Live
·
Sep 30

InSilico Medicine Nominates New Obesity Drug Candidate; Shares Jump 8%

MT Newswires Live
·
Sep 30

InSilico Medicine Jumps on Progress in Testing of New Weight-Loss Drug

Reuters
·
Sep 30

HK Movers | Pharma Stocks Jump With CanSino Biologics up 19%, Joinn Laboratories up 17%

Tiger Newspress
·
Sep 30

Insilico Medicine (03696) Nominates New-Generation Small-Molecule GIPR Antagonist with Potential for Obesity and Related Disease Intervention

Stock News
·
Sep 30

Insilico Medicine Cayman Topco - Nominates Next-Generation Gipr Antagonist for Obesity Intervention

THOMSON REUTERS
·
Sep 30

Insilico Medicine Cayman Topco - Nominates Ism1354 as Preclinical Candidate for Obesity and Related Disorders

THOMSON REUTERS
·
Sep 30

Insilico Medicine Shares Surge Nearly 8% as AI Drug Discovery Sector Continues to Heat Up, Company's BD and PCC Output Hit Record Highs

Stock News
·
Sep 30

Movement Alert|INSILICO Rises 5.96% in Regular Trading, Multi-Million Dollar AI Model Co-Development Deal Continues to Drive Momentum

Market Focus
·
Sep 30

Hong Kong Stock Movers | Insilico Medicine (03696) Rises Over 4% in Morning Trading, Recently Announced Tens of Millions of Dollars AI Model Co-Development Partnership

Stock News
·
Sep 29